Introduction
afrezza insulin that’s revolutionizing diabetes. It’s ultra-rapid-acting insulin that comes in the form of a breathable powder. Afrezza delivers 12-hour sustained blood sugar control, making it easier for people with diabetes to achieve better blood sugar control. Afrezza is also the first and only FDA-approved rapid-acting inhaled insulin for adults with type 1 and type 2 diabetes. Afrezza is a fast-acting insulin that comes in a cartridge that you insert into an inhaler. You then “inhale” it like you would an asthma medication.
What is Afrezza?
Afrezza is a product of MannKind Corporation, which is headquartered in Valencia, California. The product was developed by Al Mann, the founder and former CEO of MannKind. Afrezza was the first new insulin product to be approved in the United States in more than 20 years.
Afrezza is a rapid-acting, inhaled insulin therapy for people with diabetes. Afrezza is designed to help control blood sugar levels in adults with diabetes. Afrezza is not for everyone with diabetes. Do not use Afrezza if you are allergic to any of its ingredients.
Afrezza is a rapid-acting, ultra-rapid-acting, and mealtime insulin analogue indicated to improve glycemic control in adults with
non insulin dependent diabetes. Afrezza is not recommended for the treatment of patients with
type 1 diabetes mellitus or diabetic ketoacidosis. Afrezza consists of a dry powder that is inhaled using the
Afrezza Inhaler.
How does Afrezza work?
Afrezza is rapid-acting mealtime insulin taken just before eating to help control blood sugar levels. Afrezza is inhaled using a small, hand-held device called the Dreamboat. The Dreamboat is about the size of a marker pen and has a built-in dose counter.
Afrezza comes in cartridges that are inserted into the Dreamboat. Each cartridge contains 4 units of Afrezza. When you take a dose of Afrezza, the cartridge is automatically turned on and delivers the insulin dose over a period of 12 minutes.
Afrezza was approved by the FDA in 2014, and it has been shown to be effective in controlling blood sugar levels. In clinical trials, participants who used Afrezza had lower blood sugar levels than those who used insulin injections.
What are the benefits of using Afrezza?
Afrezza is rapid-acting mealtime insulin that can help people with type 1 or type 2 diabetes control their blood sugar levels. It comes in a cartridge that is inserted into an inhaler and delivers insulin quickly and easily.
Afrezza is a great option for people who are looking for an alternate way to take insulin, as it is easy to use and fast-acting. It can also be helpful for people who have trouble with traditional insulin injections.
How to use Afrezza?
Afrezza is available as 4 units (4 mcg), 8 units (8 mcg), 12 units (12 mcg), and 16 units (16 mcg) per inhalation. The dose of Af omnipod 5, glp1.
Do not use Afrezza if you are allergic to any of its ingredients. Before using Afrezza, tell your doctor about all of your medical conditions, including if you have lung or breathing problems, are pregnant or plan to become pregnant, are breast-feeding, It is used to control blood sugar levels after meals and can also be used as a replacement for long-acting insulin. Afrezza comes in an inhaler that you use just before you eat.
Afrezza works quickly, within 12 minutes, to help lower blood sugar levels. It starts working faster than injected insulin, and its effects last for up to 3 hours. Afrezza can be used with any meal, including those with carbohydrates.
Side effects of using Afrezza
Patients who use Afrezza may experience some side effects, but these tend to be mild and go away relatively quickly. The most common side effects are throat irritation, coughing, and headache. Less common side effects include nausea, vomiting, and a feeling of tightness in the chest. Patients with asthma or other respiratory problems should use caution when using Afrezza, as the drug may make their condition worse. Afrezza is not for everyone and can have some side effects. Some people who have used Afrezza have experienced the following side effects:
- Dizziness
- Headache
- Nausea
- Throat irritation
- • Bronchospasm (a tightening of the muscles around the airways)
- Sinus infection
Precautions when using Afrezza
There are some precautions that should be taken into account when using Afrezza. Patients with lung problems, such as asthma, should not use Afrezza. Additionally, Afrezza should not be used by pregnant women or people who are allergic to peanuts.
Afrezza should not be used by people who are allergic to insulin, or by people with lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Afrezza should not be used during episodes of low blood sugar (hypoglycemia).
Tips when using afrezza insulin
Here are some important tips on using Afrezza:
- Always use the Afrezza inhaler as directed by your doctor
- Never share your inhaler with others
- Clean the inhaler mouthpiece weekly with a mild detergent and water, then air dry
- If you have any questions or problems using Afrezza
- Afrezza is not a substitute for long-acting insulin. You will still need to take your long-acting insulin every day, and use Afrezza only when you need it to help control your blood sugar levels.
- Do not use Afrezza if you are taking other medicines to treat diabetes, such as insulin,
- Afrezza should not be used if you are allergic to any of its ingredients.
Conclusion
In conclusion, Afrezza insulin is a promising new treatment for diabetes that has shown to be both safe and effective in clinical trials. It is a fast-acting insulin that is administered through an inhaler, which makes it a convenient and discreet option for people with ada diabetes.
0 Comments